RECRUITING

Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The Accuryn Registry Study is an open-ended, global, multi-center, retrospective and prospective, single-arm data collection study with an FDA cleared device. The target population are cardiovascular surgery patients. Physiologic data measurements will be collected from enrolled subjects using electronic medical records and data streams via the Accuryn Monitoring System.

Official Title

Physiologic Signals and Signatures With the Accuryn Monitoring System - A Retrospective and Prospective Analysis (The Accuryn Registry)

Quick Facts

Study Start:2020-12-21
Study Completion:2026-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04669548

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Signed or Verbal Informed Consent as required by IRB (if applicable).
  2. 2. Adult (age ≥ 18).
  3. 3. Monitored on the Accuryn® Monitoring System during their procedure and ICU stay (for retrospective enrollment).
  4. 4. Patient is undergoing cardiac surgical intervention(s).
  1. 1. Known history of advanced chronic kidney disease defined by an estimated glomerular filtration rate (eGFR) \<20 mL/min/1.73m2 within 30 days prior to procedure.
  2. 2. The patient is unsuitable for the study, in the opinion of the investigator. This may include vulnerable patient populations such as pregnant women, prisoners ,or those detained in a penal institution.

Contacts and Locations

Study Contact

Bev Ann Blackwell
CONTACT
256-679-5422
bblackwell@potreromed.com
Ariane Marcus
CONTACT
888-635-7280
amarcus@potreromed.com

Principal Investigator

Vanessa Moll, MD, PhD
STUDY_DIRECTOR
Potrero Medical

Study Locations (Sites)

Cedars-Sinai Medical Center
Los Angeles, California, 90048
United States
San Francisco VA Medical Center
San Francisco, California, 94121
United States
George Washington University Hospital
Washington, District of Columbia, 20037
United States
Cleveland Clinic Florida
Weston, Florida, 33331
United States
Jewish Hospital / University of Louisville
Louisville, Kentucky, 40202
United States
Mission Health Hospital
Asheville, North Carolina, 28803
United States
Duke University Hospital
Durham, North Carolina, 27710
United States
Wake Forest Baptist Medical Center
Winston-Salem, North Carolina, 27157
United States
Cleveland Clinic
Cleveland, Ohio, 44195
United States

Collaborators and Investigators

Sponsor: Potrero Medical

  • Vanessa Moll, MD, PhD, STUDY_DIRECTOR, Potrero Medical

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-12-21
Study Completion Date2026-12-31

Study Record Updates

Study Start Date2020-12-21
Study Completion Date2026-12-31

Terms related to this study

Keywords Provided by Researchers

  • Acute Kidney Injury (AKI)
  • CABG
  • Cardiovascular Surgery
  • Intraabdominal Pressure (IAP)
  • Urine Output (UO)
  • Accuryn

Additional Relevant MeSH Terms

  • Intraabdominal Hypertension
  • Abdominal Compartment Syndrome
  • Acute Kidney Injury
  • Cardiovascular Surgery